Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension

Free Subscription 08.09.2025 1 Arch Dis Child Fetal Neonatal Ed 1 BMJ Case Rep 1 Br J Radiol 1 Catheter Cardiovasc Interv 1 Circ Heart Fail 1 Clin Case Rep 2 Cureus 1 Eur Heart J Case Rep 1 Eur J Pediatr 1 Eur Respir Rev 1 Expert Rev Respir Med 1 Front Med (Lausanne) 1 Int J Cardiol 1 Int J Cardiovasc Imaging 1 Integr Med Res 1 J Am Heart Assoc 1 J Cardiothorac Vasc Anesth 1 J Manag Care Spec Pharm 1 J Mol Med (Berl) 2 J Smooth Muscle Res 1 JACC Case Rep 1 JHLT Open 1 Nitric Oxide 1 Open Heart 1 Pediatr Pulmonol 1 Pflugers Arch 4 Pulm Circ 1 Pulm Pharmacol Ther 1 Quant Imaging Med Surg 1 Respir Med 1 World J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Dis Child Fetal Neonatal Ed

1. GENTLE SJ, Carlo WA, Ambalavanan N
   Screening for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia: when, how often and does it matter?
   Arch Dis Child Fetal Neonatal Ed. 2025 Sep 5:fetalneonatal-2024-328405.
   PubMed         Abstract available
   
   

   
   BMJ Case Rep

2. DAGHER C, Akiki M, Clark M, Parikh R, et al
   Neuropsychiatric reaction to treprostinil in pulmonary hypertension leading to treatment discontinuation.
   BMJ Case Rep. 2025;18:e266704.
   PubMed         Abstract available
   
   

   
   Br J Radiol

3. ABDULAAL LL, Sharkey MMJ, Maiter AA, Alabed SS, et al
   CT scoring system to Defined Thrombus Distribution in Chronic Thromboembolic Pulmonary Hypertension.
   Br J Radiol. 2025 Sep 5:tqaf221. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Catheter Cardiovasc Interv

4. ABDALLAH N, Mohamoud A
   Exploring the Relationship between Group 2 Pulmonary Hypertension and Complete Heart Block: A United States Population Based Study.
   Catheter Cardiovasc Interv. 2025 Sep 2. doi: 10.1002/ccd.70134.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

5. SCHMERMUND BN, Rieth AJ, Rademann M, Borst PC, et al
   Abnormal Left Atrial Strain by CMR is Associated with Left Heart Disease in Patients with Pulmonary Hypertension.
   Circ Heart Fail. 2025 Aug 31. doi: 10.1161/CIRCHEARTFAILURE.125.013480.
   PubMed         Abstract available
   
   

   
   Clin Case Rep

6. FARANDZHA D, Gatzov P, Velchev V
   Massive Right Atrium due to Severe Pulmonary Hypertension Mimicking Biatrial Enlargement on ECG.
   Clin Case Rep. 2025;13:e70835.
   PubMed         Abstract available
   
   

   
   Cureus

7. POKIMA N, Gill S, Moradi R, Thida AM, et al
   Pulmonary Hypertension in Sickle Cell Disease: A Case Series.
   Cureus. 2025;17:e89012.
   PubMed         Abstract available
   
   
8. KRISHNAN S, Ramalingam V, Adigopula S, Gadeela N, et al
   Prevalence of Pulmonary Hypertension in Patients With Pulmonary Langerhans Cell Histiocytosis: A Systematic Review and Meta-Analysis.
   Cureus. 2025;17:e89111.
   PubMed         Abstract available
   
   

   
   Eur Heart J Case Rep

9. CASTILLO-TELLO C, Barron-Magdaleno C, Orihuela-Sandoval C, Gutierrez-Leon E, et al
   Parkes Weber syndrome, a rare case of pulmonary hypertension: a case report.
   Eur Heart J Case Rep. 2025;9:ytaf381.
   PubMed         Abstract available
   
   

   
   Eur J Pediatr

10. FARAG MM, Ghazal HAE, Abdel-Mohsen AM, Rezk MA, et al
    Nebulized nitroglycerin as an adjuvant drug in management of persistent pulmonary hypertension of newborns: a randomized controlled trial.
    Eur J Pediatr. 2025;184:586.
    PubMed         Abstract available
    
    

    
    Eur Respir Rev

11. RIBEIRO IC, Sieczkowska SM, Jashchenko R, Jara D, et al
    Effectiveness and safety of home-based versus centre-based exercise programmes for pulmonary hypertension: a systematic review with meta-analysis.
    Eur Respir Rev. 2025;34:250102.
    PubMed         Abstract available
    
    

    
    Expert Rev Respir Med

12. TOUIL A, Bouden S, Maazaoui S, Rouached L, et al
    Rituximab treatment for connective tissue diseases associated-pulmonary hypertension: a systematic literature review.
    Expert Rev Respir Med. 2025 Sep 4. doi: 10.1080/17476348.2025.2557634.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

13. LIU Y, Guo X, Liu P, Jia S, et al
    Rehabilitation applications and progress in managing pulmonary hypertension.
    Front Med (Lausanne). 2025;12:1659818.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

14. ARSHAD A, Melin M, Lund LH, Manouras A, et al
    Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification.
    Int J Cardiol. 2025;440:133729.
    PubMed         Abstract available
    
    

    
    Int J Cardiovasc Imaging

15. ABBAS MT, Farina JM, Mahmoud AK, Wraith RE, et al
    Right ventricular strain enhances the REVEAL LITE score for predicting 1-Year mortality in pulmonary hypertension.
    Int J Cardiovasc Imaging. 2025 Aug 30. doi: 10.1007/s10554-025-03506.
    PubMed         Abstract available
    
    

    
    Integr Med Res

16. NA SW, Kim HY, Yoon JJ, Hong MH, et al
    Therapeutic effects of Gunryeong-tang on the cardio-renal axis in an animal model of pulmonary hypertension.
    Integr Med Res. 2025;14:101218.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

17. HUNGERFORD SL, Gulati G, Everett K, Kearney K, et al
    Assessment of Ventriculo-Arterial Interactions in Early and Undifferentiated Pulmonary Hypertension Using Wave Intensity Analysis.
    J Am Heart Assoc. 2025 Aug 29:e042831. doi: 10.1161/JAHA.125.042831.
    PubMed         Abstract available
    
    

    
    J Cardiothorac Vasc Anesth

18. MORALES-DEMORI R, Ortoleva J, Aras S, Anders M, et al
    Outcomes of Extracorporeal Membrane Oxygenation in Patients with COVID-19 and Pulmonary Hypertension: An ELSO Registry Analysis.
    J Cardiothorac Vasc Anesth. 2025 Aug 6:S1053-0770(25)00653.
    PubMed         Abstract available
    
    

    
    J Manag Care Spec Pharm

19. EL-KERSH K, Zawadzki N, Watzker A, Zhang S, et al
    A structured approach for identifying disease analogs for pulmonary arterial hypertension.
    J Manag Care Spec Pharm. 2025;31:909-921.
    PubMed         Abstract available
    
    

    
    J Mol Med (Berl)

20. ZHENG R, Tan J, Cao X, Wang S, et al
    Rewriting the vascular script: epigenetic modifiers as scribes of metabolic reprogramming in pulmonary hypertension.
    J Mol Med (Berl). 2025 Sep 3. doi: 10.1007/s00109-025-02589.
    PubMed         Abstract available
    
    

    
    J Smooth Muscle Res

21. ETO M, Yamazawa T, Kurahara LH, Yamamura A, et al
    Expanding diverse horizons in smooth muscle research: a symposium review of "Muscle and Pathology/Health: Frontiers of Translational Research" at the 66th Annual Meeting of Japan Society of Smooth Muscle Research.
    J Smooth Muscle Res. 2025;61:59-64.
    PubMed         Abstract available
    
    
22. YAMAMURA A
    Growth factors involved in vascular remodeling in pulmonary arterial hypertension.
    J Smooth Muscle Res. 2025;61:82-92.
    PubMed         Abstract available
    
    

    
    JACC Case Rep

23. ABEN R, Burton T, Fathieh F, Nemati N, et al
    Facilitating Earlier Diagnosis of Pulmonary Hypertension Using a Novel Noninvasive Diagnostic.
    JACC Case Rep. 2025;30:104876.
    PubMed         Abstract available
    
    

    
    JHLT Open

24. VERBELEN T, Fadel E, Wiedenroth CB, Jenkins DP, et al
    Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Technical challenges and controversies.
    JHLT Open. 2025;10:100357.
    PubMed         Abstract available
    
    

    
    Nitric Oxide

25. LIU Z, Cui B, Ju H, Tan T, et al
    Catestatin alleviates PASMC phenotypic switching-mediated pulmonary arterial remodeling in a rat model of MCT-induced pulmonary arterial hypertension by promoting endothelium-derived no synthesis.
    Nitric Oxide. 2025;158:93-105.
    PubMed         Abstract available
    
    

    
    Open Heart

26. TAKANO R, Tatsuo A, Fujisaki S, Akao M, et al
    Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
    Open Heart. 2025;12:e003532.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

27. GARCIA-GOZALO M, Pellicer A, Bravo MC
    Current Practices for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonates: A Survey Study in Spain.
    Pediatr Pulmonol. 2025;60:e71259.
    PubMed         Abstract available
    
    

    
    Pflugers Arch

28. DE CASTRO AL, Turck P, Tavares AMV, Gaspar CJ, et al
    Evaluation of the use of the myocardial performance index as a parameter of cardiac function in two experimental models of heart disease: myocardial infarction and pulmonary hypertension.
    Pflugers Arch. 2025 Aug 30. doi: 10.1007/s00424-025-03117.
    PubMed         Abstract available
    
    

    
    Pulm Circ

29. HARDY L, D'Haenens A, Belmans A, Quarck R, et al
    Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70136.
    PubMed         Abstract available
    
    
30. ZICANS M, Sablinskis K, Cesnieks H, Rudzitis A, et al
    Chronic Thromboembolic Pulmonary Hypertension in Latvia: Epidemiological Insights and Diagnostic Challenges From 2024.
    Pulm Circ. 2025;15:e70159.
    PubMed         Abstract available
    
    
31. HUMPL T, Berger RMF, Bonnet D, Beghetti M, et al
    How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension).
    Pulm Circ. 2025;15:e70146.
    PubMed         Abstract available
    
    
32. NICCUM M, Avitabile CM, Albizem D, Meluskey H, et al
    Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model.
    Pulm Circ. 2025;15:e70156.
    PubMed         Abstract available
    
    

    
    Pulm Pharmacol Ther

33. CONNELLY D, Delahanty J, Patel S, Ackerbauer KA, et al
    Inhaled epoprostenol for management of acute respiratory failure and pulmonary vascular disease.
    Pulm Pharmacol Ther. 2025;90:102374.
    PubMed         Abstract available
    
    

    
    Quant Imaging Med Surg

34. MA J, Li W, Xu S, Ren R, et al
    Noninvasive assessment of pulmonary vascular resistance: a synergistic approach using computed tomography pulmonary angiography and echocardiography in pulmonary hypertension.
    Quant Imaging Med Surg. 2025;15:8567-8578.
    PubMed         Abstract available
    
    

    
    Respir Med

35. ALHARBI A, Biyari A, Basuwdan A, Alrodiman O, et al
    Prognostic performance of the 3- and 4-strata ESC/ERS risk stratification models in Pulmonary Arterial Hypertension: A validation study in a Saudi Arabian cohort.
    Respir Med. 2025;247:108257.
    PubMed         Abstract available
    
    

    
    World J Gastroenterol

36. GOPALAKRISHNA H, Nguyen ML, Mironova M, Viana Rodriguez GM, et al
    Cardiopulmonary changes and its association with clinical features in noncirrhotic portal hypertension.
    World J Gastroenterol. 2025;31:109256.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.